[go: up one dir, main page]

BG103933A - 5-(2-ethyl-2h-tetrazol-5-yl)-1-methyl-1,2,3,6- tetrahydropyridine maleate - Google Patents

5-(2-ethyl-2h-tetrazol-5-yl)-1-methyl-1,2,3,6- tetrahydropyridine maleate

Info

Publication number
BG103933A
BG103933A BG103933A BG10393399A BG103933A BG 103933 A BG103933 A BG 103933A BG 103933 A BG103933 A BG 103933A BG 10393399 A BG10393399 A BG 10393399A BG 103933 A BG103933 A BG 103933A
Authority
BG
Bulgaria
Prior art keywords
ethyl
methyl
tetrazol
tetrahydropyridine
maleate
Prior art date
Application number
BG103933A
Other languages
Bulgarian (bg)
Inventor
Sommer Michael Bech
Ole Nielsen
Original Assignee
H. Lundbeck A/S
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by H. Lundbeck A/S filed Critical H. Lundbeck A/S
Publication of BG103933A publication Critical patent/BG103933A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

The invention relates to an adjunctive salt of the maleic acid of 2-ethyl-5-(1-methyl-1,2,3,6-tetrahydro-3-pyridyl)-2H- tetrazole, to pharmaceutical compositions containing the adjunctive with acid salt, and to its application in the treatment of disorders caused by dysfunction of the acetylcholine (AcCh) or muscarine system.
BG103933A 1997-07-01 1999-11-30 5-(2-ethyl-2h-tetrazol-5-yl)-1-methyl-1,2,3,6- tetrahydropyridine maleate BG103933A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK78197 1997-07-01
PCT/DK1998/000294 WO1999001448A1 (en) 1997-07-01 1998-07-01 5-(2-ethyl-2h-tetrazol-5-y1)-1-methyl-1,2,3,6-tetrahydropyridine maleate

Publications (1)

Publication Number Publication Date
BG103933A true BG103933A (en) 2000-07-31

Family

ID=8097489

Family Applications (1)

Application Number Title Priority Date Filing Date
BG103933A BG103933A (en) 1997-07-01 1999-11-30 5-(2-ethyl-2h-tetrazol-5-yl)-1-methyl-1,2,3,6- tetrahydropyridine maleate

Country Status (25)

Country Link
EP (1) EP0994869A1 (en)
JP (1) JP2002507215A (en)
KR (1) KR20010014297A (en)
CN (1) CN1261361A (en)
AR (1) AR013096A1 (en)
AU (1) AU735751B2 (en)
BG (1) BG103933A (en)
BR (1) BR9810331A (en)
CA (1) CA2293324A1 (en)
CO (1) CO4940483A1 (en)
EA (1) EA200000081A1 (en)
HU (1) HUP0002876A2 (en)
IL (1) IL133093A0 (en)
IS (1) IS5278A (en)
JO (1) JO2031B1 (en)
MA (1) MA25138A1 (en)
NO (1) NO996580L (en)
PE (1) PE116099A1 (en)
PL (1) PL337184A1 (en)
SK (1) SK187399A3 (en)
TN (1) TNSN98120A1 (en)
TR (1) TR199903283T2 (en)
UY (2) UY25069A1 (en)
WO (1) WO1999001448A1 (en)
ZA (1) ZA985498B (en)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8714789D0 (en) * 1987-06-24 1987-07-29 Lundbeck & Co As H Heterocyclic compounds
CZ287441B6 (en) * 1995-11-06 2000-11-15 Lundbeck & Co As H Pharmaceutical preparation for treating traumatic lesion of brain

Also Published As

Publication number Publication date
AU735751B2 (en) 2001-07-12
EA200000081A1 (en) 2000-08-28
PL337184A1 (en) 2000-08-14
TR199903283T2 (en) 2000-06-21
JP2002507215A (en) 2002-03-05
BR9810331A (en) 2000-09-05
CA2293324A1 (en) 1999-01-14
ZA985498B (en) 1999-01-20
CO4940483A1 (en) 2000-07-24
UY25177A1 (en) 2000-12-29
NO996580D0 (en) 1999-12-30
SK187399A3 (en) 2000-06-12
PE116099A1 (en) 1999-11-23
UY25069A1 (en) 1998-12-21
AR013096A1 (en) 2000-12-13
CN1261361A (en) 2000-07-26
NO996580L (en) 1999-12-30
MA25138A1 (en) 2001-04-02
HUP0002876A2 (en) 2001-06-28
EP0994869A1 (en) 2000-04-26
JO2031B1 (en) 1999-05-15
WO1999001448A1 (en) 1999-01-14
TNSN98120A1 (en) 2005-03-15
IL133093A0 (en) 2001-03-19
IS5278A (en) 1999-11-30
AU8102098A (en) 1999-01-25
KR20010014297A (en) 2001-02-26

Similar Documents

Publication Publication Date Title
DE69528823D1 (en) Morpholinwirkstoffvorläufer als tachykininreceptorantagonisten
MXPA04002982A (en) Pyrrolidinone derivatives.
CA2297911A1 (en) Substituted 6-phenylphenanthridines
YU59098A (en) Substituted spiro-piperidine derivatives
PT1053256E (en) Antibodies to death receptor 4 (dr4) and uses thereof
MY134806A (en) Cyclosporins
EP1808177A3 (en) Methods of treatment of mitochondrial disorders
ATE300533T1 (en) 1,2,3,4-TETRAHYDROISOCINOLINE DERIVATIVES AS UROTENSIN II RECEPTOR ANTAGONISTS
BG102425A (en) (methylsulphonyl)phenyl-2-(5h)-furanons as cyclooxygenase-2-inhibitors
IL118544A0 (en) Substituted amino pyridyl and pyrimidine containing compounds
TR200000015T2 (en) Compounds and methods
HUT73807A (en) 5-ht1-like indole derivatives and pharmaceutical compositions containing them
CA2250569A1 (en) Novel phenanthridines substituted in the 6 position
EP2213302A3 (en) DR4 antibodies and uses thereof
EP0627221A3 (en) Substance P antagonists for the treatment of vomiting.
WO1999045098A3 (en) Delivery or proteins into eukaryotic cells with recombinant yersinia
BG105256A (en) Muscarinic agonists and antagonists
BG105761A (en) Substituted 2-arylimino heterocycles and compositions containing them, for use as progesterone receptor binding agents
WO2001010408A3 (en) Aqueous pharmaceutical composition containing moxifloxacin or salts thereof
KR100292396B1 (en)
BG103933A (en) 5-(2-ethyl-2h-tetrazol-5-yl)-1-methyl-1,2,3,6- tetrahydropyridine maleate
AP2000001946A0 (en) Form V1 5,6-Dichloro-2-(isopropylamino)-1-(B-L-Ribofuranosyl)-1H- benzimidazole.
NO991734L (en) Pyrazolinones for the treatment of potency disorders
YU46302A (en) Substituted pyrroles
FR2710844B1 (en) Composition for the treatment or prevention of herpes.